About Future PharmaTech
Future PharmaTech Inc., founded in 2021, is a biotech company advancing AI-powered drug discovery and nanomedicine to develop safe, effective, and targeted therapies. Our focus is on challenging conditions such as dementia and erectile dysfunction.
Our core technology, the Future-AI platform, combines drug repurposing and mechanism-based simulation to optimize brain-targeted delivery and improve treatment outcomes.
Led by Dr. Ming-Wei Chao, a U.S.-certified toxicologist, our team brings together experts in medicine, AI, and business. We collaborate globally to shorten the drug development timeline and bring breakthrough therapies to patients faster.
Our Vision
Medicine can heal—or harm. At Future PharmaTech, we believe that great therapies must strike the right balance between efficacy and safety.
Traditional drug development is slow, costly, and often burdened with side effects or delayed benefits. We are changing that.
With our proprietary Future‑AI platform, we design 505(b)(2) combination therapies that merge pharmaceutical science, technology, and human-centered care—optimizing every molecule and delivery path.
Our vision is to bring innovative therapies to patients—faster, safer, and with real impact.
Future PharmaTech — The future of medicine, caring for your life.
Innovation-Driven
We challenge conventions with forward-thinking drug development.
Collaborative Culture
Cross-functional teamwork is at the heart of every solution we deliver.
Safety First
Patient safety is our foundation throughout every stage of research.
Pursuit of Excellence
We constantly optimize our process to achieve greater clinical value.
